Connection

Prabhakar Baliga to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications Prabhakar Baliga has written about Antibodies, Monoclonal.
Prabhakar Baliga
Connection Strength
1.262
Antibodies, Monoclonal
  1. Efficacy of induction therapy on acute rejection and graft outcomes in African American kidney transplantation. Clin Transplant. 2010 Jan-Feb; 24(1):40-7.
    View in: PubMed
    Score: 0.269
  2. Long-term efficacy of induction therapy with anti-interleukin-2 receptor antibodies or thymoglobulin compared with no induction therapy in renal transplantation. Transplant Proc. 2008 Dec; 40(10):3401-7.
    View in: PubMed
    Score: 0.265
  3. Enhanced allograft survival via simultaneous blockade of transferrin receptor and interleukin-2 receptor. Transplantation. 1999 Nov 15; 68(9):1369-76.
    View in: PubMed
    Score: 0.141
  4. T-cell alterations in cardiac allograft recipients after B7 (CD80 and CD86) blockade. Transplantation. 1998 Jul 15; 66(1):14-20.
    View in: PubMed
    Score: 0.129
  5. Anti-transferrin receptor monoclonal antibody: a novel immunosuppressant. Transplantation. 1998 Jan 15; 65(1):6-9.
    View in: PubMed
    Score: 0.124
  6. Cytolytic Induction Therapy Improves Clinical Outcomes in African-American Kidney Transplant Recipients. Ann Surg. 2017 09; 266(3):450-456.
    View in: PubMed
    Score: 0.121
  7. Prospective randomized controlled trial of rabbit antithymocyte globulin compared with IL-2 receptor antagonist induction therapy in kidney transplantation. Ann Surg. 2014 May; 259(5):888-93.
    View in: PubMed
    Score: 0.096
  8. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways. Transplantation. 1996 Oct 15; 62(7):1011-8.
    View in: PubMed
    Score: 0.029
  9. OKT4 epitope correlates with renal allograft survival in African Americans. Cytometry. 1994 Jun 15; 18(2):93-4.
    View in: PubMed
    Score: 0.024
  10. Anti-CD48 (murine CD2 ligand) mAbs suppress cell mediated immunity in vivo. Int Immunol. 1994 May; 6(5):701-9.
    View in: PubMed
    Score: 0.024
  11. Combination anti-CD2 and anti-CD3 monoclonal antibodies induce tolerance while altering interleukin-2, interleukin-4, tumor necrosis factor, and transforming growth factor-beta production. Ann Surg. 1993 Oct; 218(4):492-501; discussion 501-3.
    View in: PubMed
    Score: 0.023
  12. Differential effects of transferrin receptor blockade on the cellular mechanisms involved in graft rejection. Transpl Immunol. 1999 Sep; 7(3):131-9.
    View in: PubMed
    Score: 0.009
  13. Transferrin receptor in T cell activation and transplantation. J Leukoc Biol. 1998 Jul; 64(1):19-24.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.